Tarsus Pharmaceuticals Stock Price on May 6, 2024
| TARS Stock | USD 52.91 0.91 1.75% |
Below is the normalized historical share price chart for Tarsus Pharmaceuticals extending back to October 16, 2020. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Tarsus Pharmaceuticals stands at 52.91, as last reported on the 22nd of December, with the highest price reaching 53.62 and the lowest price hitting 50.20 during the day.
If you're considering investing in Tarsus Stock, it is important to understand the factors that can impact its price. Tarsus Pharmaceuticals appears to be very steady, given 3 months investment horizon. Tarsus Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.29, which indicates the firm had a 0.29% return per unit of risk over the last 3 months. By inspecting Tarsus Pharmaceuticals' technical indicators, you can evaluate if the expected return of 0.75% is justified by implied risk. Please review Tarsus Pharmaceuticals' Semi Deviation of 1.54, risk adjusted performance of 0.2081, and Coefficient Of Variation of 394.08 to confirm if our risk estimates are consistent with your expectations.
At this time, Tarsus Pharmaceuticals' Other Stockholder Equity is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 20.8 M in 2024, whereas Common Stock Total Equity is likely to drop 3,520 in 2024. . At this time, Tarsus Pharmaceuticals' Price To Sales Ratio is comparatively stable compared to the past year. Price Book Value Ratio is likely to gain to 3.17 in 2024, despite the fact that Price Earnings To Growth Ratio is likely to grow to (0.05). Tarsus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of October 2020 | 200 Day MA 34.8374 | 50 Day MA 45.8575 | Beta 1.004 |
Tarsus |
Sharpe Ratio = 0.2857
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | TARS | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.64 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.75 actual daily | 14 86% of assets have higher returns |
Risk-Adjusted Return
| 0.29 actual daily | 22 78% of assets perform better |
Based on monthly moving average Tarsus Pharmaceuticals is performing at about 22% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Tarsus Pharmaceuticals by adding it to a well-diversified portfolio.
Price Book 8.5151 | Enterprise Value Ebitda (3.23) | Price Sales 15.6038 | Shares Float 29 M | Wall Street Target Price 65.3333 |
Related Headline
Inhibrx Headline on 6th of May 2024
Filed transaction by InhibrxInc Officer: Chief Financial Officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
Tarsus Pharmaceuticals Valuation on May 6, 2024
It is possible to determine the worth of Tarsus Pharmaceuticals on a given historical date. On May 6, 2024 Tarsus was worth 37.0 at the beginning of the trading date compared to the closed value of 37.03. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Tarsus Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Tarsus Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Tarsus Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Tarsus Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 35.75 | 37.14 | 35.51 | 36.85 | 684,003 | |
05/06/2024 | 37.00 | 37.85 | 36.35 | 37.03 | 679,559 |
| 36.68 | 38.43 | 36.15 | 38.03 | 635,634 |
| Backtest Tarsus Pharmaceuticals | | | Tarsus Pharmaceuticals History | | | Tarsus Pharmaceuticals Valuation | Previous | Next |
Tarsus Pharmaceuticals Trading Date Momentum on May 6, 2024
| On May 07 2024 Tarsus Pharmaceuticals was traded for 38.03 at the closing time. The top price for the day was 38.43 and the lowest listed price was 36.15 . The trading volume for the day was 635.6 K. The trading history from May 7, 2024 was a factor to the next trading day price appreciation. The trading price change against the next closing price was 2.70% . The trading price change against the current closing price is 3.97% . |
Tarsus Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Tarsus Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Tarsus Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Tarsus financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Tarsus Pharmaceuticals Stock history
Tarsus Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Tarsus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Tarsus Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Tarsus Pharmaceuticals stock prices may prove useful in developing a viable investing in Tarsus Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 29.4 M | 21.8 M | |
| Net Loss | -55.9 M | -53.1 M |
Tarsus Pharmaceuticals Quarterly Net Working Capital |
|
Tarsus Pharmaceuticals Stock Technical Analysis
Tarsus Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Tarsus Pharmaceuticals Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Tarsus Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Tarsus Pharmaceuticals December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Tarsus Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Tarsus Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Tarsus Pharmaceuticals stock market strength indicators, traders can identify Tarsus Pharmaceuticals entry and exit signals to maximize returns
Tarsus Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Tarsus Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Tarsus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Tarsus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.2081 | |||
| Jensen Alpha | 0.6505 | |||
| Total Risk Alpha | 0.5952 | |||
| Sortino Ratio | 0.3452 | |||
| Treynor Ratio | 0.751 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Tarsus Stock Analysis
When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.